Search
for
Sort by
Research 241–270 of 1000+
- Acute dermal and ocular irritation testing of rice bran supercritical CO2 extract (RB-SCE) and 0.5% RB-SCE essence product
- Novel prospectives of shikimic acid and Prunus mume extract for enhancing bioactivity on 5α-reductase and stability in cosmetic patches for acne treatment
- HPLC Profiling and Insilco studies of Chochurus olitoris (Jute) Leave Fractions against Steroid 5α-Reductase 2 (SRD5α2)
- Alopecia areata susceptibility variant identified by MHC risk haplotype sequencing reproduces symptomatic patched hair loss in mice
- Differentiation of Human Dermal Mesenchymal Stem Cells into Cardiomyocytes by Treatment with 5-Azacytidine: Concept for Regenerative Therapy in Myocardial Infarction
- Cardiometabolic risk factors in women with non-classic congenital adrenal hyperplasia
- 5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia
- Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates
- Risk factors associated with development and persistence of long COVID
- Gender-specific risk factors for androgenetic alopecia in the Korean general population: Associations with medical comorbidities and general health behaviors
- Risk factors for prostate cancer: a case-control study investigating selected key exposures and their interactions with predisposition genes
- A population-based study of the risk of osteoporosis and fracture with dutasteride and finasteride
- Discovery of Natural Steroid 5 Alpha-Reductase Inhibitors
- Medical and Environmental Risk Factors for the Development of Central Centrifugal Cicatricial Alopecia
- Production of 5α-Reduced Neurosteroids Is Developmentally Regulated and Shapes GABA<sub>A</sub>Miniature IPSCs in Lamina II of the Spinal Cord
- Androgen receptor gene polymorphisms and risk for androgenetic alopecia: a meta-analysis
- Evidence for Increased 5α-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome
- Anabolic-androgenic steroids and cardiovascular risk
- Inhibition of 5α Reductase Impairs Cognitive Performance, Alters Dendritic Morphology and Increases Tau Phosphorylation in the Hippocampus of Male 3xTg-AD Mice
- Clinical use of 5α-reductase inhibitors
- Novel type 1 5a-reductase Inhibitors with Antiproliferative Potential on LNCaP cells
- Association between SQSTM1 dysregulation and risk in alopecia areata: a Mendelian randomization study
- Total prostate volume as risk factor for semen pathologies in ageing male
- Cutaneous drug reactions
- Efficacy and safety of topical 5% minoxidil in treatment of androgenetic alopecia
- Evaluation of hyperandrogenemia and metabolic risk profile in women with postadolescent acne
- Longer TA repeat but not V89L polymorphisms in the SRD5A2 gene may confer acne risk in the Chinese population
- Comparison of Finasteride and Dutasteride on Risk of Prostate Cancer in Patients with Benign Prostatic Hyperplasia: A Pooled Analysis of 15 Real-world Databases
- Real-world pharmacovigilance insights into drug-induced risk of alopecia
- Longitudinal clinical course in patients with 5α-reductase type 2 deficiency treated with testosterone and dihydrotestosterone during infancy and puberty